Patent · US Active

Stable formulations for lyophilizing therapeutic particles

US8357401B2 · kind B2 · utility

28Cited by
23References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2010
Grant dateJan 22, 2013
Priority date
Expiry dateJul 28, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/906
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure generally relates to lyophilized pharmaceutical compositions comprising polymeric nanoparticles which, upon reconstitution, have low levels of greater than 10 micron size particles. Other aspects of the invention include methods of making such nanoparticles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.